This study was aimed at evaluating the efficacy of different endovascular treatments for early and mid-stage clinical interventions in patients with autologous arteriovenous fistulae loss of function and the corresponding health economic value.
Hemodialysis patients over 18 years of age and under 80 years of age
Autologous arteriovenous fistula cannot be used in patients completing haemodialysis
The guidewire must pass through at least the stenosis of the endovascular fistula on the side of the lesion and undergo further endovascular treatment before enrolment, and this study does not limit the form of the guidewire passing through the target lesion.
Patients who have failed to open the initial target lesion and are successful on a second attempt at endoluminal therapy may still be enrolled.
Planned kidney transplant or conversion to peritoneal dialysis
Women who are pregnant, breastfeeding or planning to become pregnant during the study period
Recent (within 30 days) or planned surgical procedure for haemodialysis access
Allergy or contraindication to heparin, contrast media, antiplatelet drugs